A detailed history of Lido Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Lido Advisors, LLC holds 10,500 shares of AMRN stock, worth $5,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,500
Previous 37,773 72.2%
Holding current value
$5,775
Previous $26,000 76.92%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.57 - $0.8 $15,545 - $21,818
-27,273 Reduced 72.2%
10,500 $6,000
Q1 2024

May 15, 2024

BUY
$0.82 - $1.35 $3,280 - $5,400
4,000 Added 11.84%
37,773 $33,000
Q2 2023

Aug 09, 2023

SELL
$1.12 - $1.49 $8,960 - $11,920
-8,000 Reduced 19.15%
33,773 $40,000
Q1 2023

May 15, 2023

BUY
$1.19 - $2.19 $9,520 - $17,520
8,000 Added 23.69%
41,773 $62,000
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $545 - $835
-500 Reduced 1.46%
33,773 $36,000
Q2 2022

Aug 15, 2022

BUY
$1.13 - $3.69 $38,728 - $126,467
34,273 New
34,273 $51,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.